American Oriental Bioengineering Inc (AOBI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2009 | 09-2009 | 06-2009 | 03-2009 | 12-2008 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 94,425 | 115,923 | 100,730 | 73,900 | 70,637 |
| Receivables | 57,505 | 37,962 | 31,397 | 32,637 | 36,982 |
| Inventories | 10,016 | 15,292 | 16,830 | 17,954 | 13,042 |
| Income taxes - deferred | 825 | 399 | 422 | 456 | 347 |
| Other current assets | 15,148 | 4,075 | 4,154 | 10,542 | 11,444 |
| TOTAL | $177,917 | $173,651 | $153,533 | $135,488 | $132,452 |
| Non-Current Assets | |||||
| PPE Net | 95,468 | 96,085 | 96,152 | 97,192 | 98,154 |
| Investments And Advances | 57,326 | 54,995 | 55,452 | 55,554 | 54,963 |
| Intangibles | 205,464 | 207,309 | 197,991 | 199,289 | 205,843 |
| Other Non-Current Assets | 40,307 | 30,293 | 37,669 | 11,661 | 37,263 |
| TOTAL | $398,565 | $388,683 | $387,264 | $363,697 | $396,224 |
| Total Assets | $576,482 | $562,334 | $540,797 | $524,861 | $528,676 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 60 | 60 | 59 | 59 | 59 |
| Accounts payable and accrued liabilities | 29,818 | 29,639 | 26,800 | 23,934 | 32,055 |
| Other current liabilities | 2,199 | 2,335 | 2,511 | 2,738 | 2,253 |
| TOTAL | $46,974 | $47,056 | $40,850 | $38,449 | $45,369 |
| Non-Current Liabilities | |||||
| Long Term Debt | 744 | 760 | 775 | 790 | 1,074 |
| Other Non-Current Liabilities | 117,747 | 116,903 | 115,123 | 114,996 | 115,000 |
| TOTAL | $134,452 | $133,165 | $131,738 | $131,892 | $133,710 |
| Total Liabilities | $181,426 | $180,221 | $172,588 | $170,341 | $179,079 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 78 | 78 | 78 | 78 | 78 |
| Common Shares | 466 | 369 | 390 | 255 | 455 |
| Retained earnings | 191,174 | 179,501 | 171,020 | 157,790 | 149,753 |
| Other shareholders' equity | 3,585 | 2,878 | 45 | 121 | 2,342 |
| TOTAL | $395,056 | $382,113 | $368,208 | $354,520 | $349,597 |
| Total Liabilities And Equity | $576,482 | $562,334 | $540,797 | $524,861 | $528,676 |